Skip to main content
  1. Market Insights
  2. Health
  3. OTC Pharmaceuticals

Analgesics - North America

North America
  • In North America, the Analgesics market generates a revenue of US$8.16bn in 2024.
  • It is projected to grow at an annual rate of 4.87% (CAGR 2024-2029).
  • Among all countries, the United States leads in terms of revenue generation, with US$7.24bn in 2024.
  • When considering the population, the per person revenue stands at US$16.00 in 2024.
  • The analgesics market in North America is witnessing a rise in demand for natural and herbal remedies.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

In-Scope

  • Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
  • Natural and synthetic agents
  • In the form of pills, capsules, gels and ointments

Out-Of-Scope

  • Prescription medicines
  • Homeopathic remedies
  • Anesthetics
Analgesics: market data & analysis - Cover

Market Insights Report

Analgesics: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The Analgesics market in North America is experiencing steady growth due to various factors.

    Customer preferences:
    Customers in North America have a high demand for analgesics due to the increasing prevalence of chronic pain conditions such as arthritis and back pain. Additionally, the aging population in the region is also contributing to the growing demand for pain relief medications. Customers in North America are also becoming more conscious about their health and are opting for over-the-counter analgesics as a first line of treatment for minor aches and pains.

    Trends in the market:
    One of the key trends in the Analgesics market in North America is the increasing popularity of natural and herbal analgesics. Customers are seeking alternatives to traditional pain relief medications and are turning towards natural ingredients such as turmeric, ginger, and CBD oil for pain management. This trend is driven by the growing awareness of the potential side effects of synthetic analgesics and the desire for more holistic approaches to healthcare.Another trend in the market is the rising demand for topical analgesics. These products are gaining popularity among customers in North America as they provide targeted pain relief without the need for oral medication. Topical analgesics are particularly favored by athletes and individuals with musculoskeletal injuries as they can be applied directly to the affected area for immediate relief.

    Local special circumstances:
    The legalization of cannabis for medical and recreational use in some states in North America has had a significant impact on the Analgesics market. Cannabis-derived products, such as CBD oil, are gaining traction as alternative pain relief options. Customers are increasingly seeking out these products for their potential analgesic properties, as well as for their perceived therapeutic benefits.

    Underlying macroeconomic factors:
    The growing healthcare expenditure in North America is driving the growth of the Analgesics market. With increasing healthcare costs, patients are looking for cost-effective solutions for pain management, leading to a higher demand for over-the-counter analgesics. Additionally, the strong presence of pharmaceutical companies in the region and their continuous investment in research and development of new analgesic drugs are also contributing to the growth of the market.In conclusion, the Analgesics market in North America is witnessing steady growth due to customer preferences for over-the-counter pain relief medications, the increasing popularity of natural and herbal analgesics, and the rising demand for topical analgesics. The legalization of cannabis and the growing healthcare expenditure in the region are also significant factors driving the market.

    Key Players

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Sales Channels

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Global Comparison

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

    Modeling approach / Market size:

    Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

    Health

    Access more Market Insights on Health topics with our featured report

    Analgesics: market data & analysis - BackgroundAnalgesics: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.